Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis

Nephron

Volumn 91, Issue 1, 2002, Pages 94-102

  Hampson, Geeta ^a   Vaja, S ^a   Evans, C ^b   Chesters, C A ^c   Pettit, R ^b   Evans, W ^b   Thomas, D ^b   Seed, P T ^d   Fraser, W D ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bone markers; Bone mineral density; Dialysis; Renal osteodystrophy

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1 C TERMINAL PROPEPTIDE; CREATININE; DEOXYPYRIDINOLINE; PARATHYROID HORMONE; PHOSPHORUS; PYRIDINOLINE; UNCLASSIFIED DRUG; UREA;

ADULT; AGE; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DIALYSATE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOREARM; GENDER; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; STATISTICAL SIGNIFICANCE; TRABECULAR BONE; UREA BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CROSS-LINKING REAGENTS; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PYRIDINIUM COMPOUNDS; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 0036092295     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057610     Document Type: Article

References (20)

1. Pathogenesis and histology of renal osteodystrophy
2. Fractures and vertebral bone mineral density in patients with renal osteodystrophy
3. Mineralized bone loss at different sites in dialysis patients: Implications for prevention
4. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory dialysis
5. Bone density at various sites for prediction of hip fractures
6. Renal osteodystrophy
7. Relationship of bone turnover to bone density and fractures
8. Circulating biochemical markers of bone remodelling in uremic patients
9. The role of bone biopsy in clinical practice and research
10. The spectrum of bone disease in end-stage renal failure: An evolving disorder
11. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in haemodialysis patients
12. Plasma total versus bone alkaline phosphatase as markers of bone turnover in haemodialysis patients
13. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy
14. Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis
15. 3 in chronic renal failure
16. Role of cytokines in renal osteodystrophy
17. Bone mineral density in patients with end-stage renal failure
18. The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients
19. Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology
20. Can bone histomorphometry be predicted by clinical assessment and non-invasive techniques in peritoneal dialysis?